← Evidence map

TrialAge (Dordrecht, Netherlands)2016

Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance.

Sara E Espinoza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27585671